Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Jurnal Ilmu Kedokteran (Journal of Medical Science) Jurnal Respirologi Indonesia
Marlina Tasril
Universitas Riau
Biochemistry, Genetics & Molecular Biology Dentistry Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Profil and Evaluation of Resistant Tuberculosis Drug’s Side Effect in Diabetes and Non Diabetes Mellitus Patient at RSUD Arifin Achmad Dani Rosdiana; Dewi Anggraini; Indra Yovi; Marlina Tasril
Jurnal Respirologi Indonesia Vol 40, No 3 (2020)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v40i3.119

Abstract

Backgrounds: Diabetes mellitus (DM) increases the risk of reactivation of tuberculosis included multi-resistant drug tuberculosis (MDR-TB). This situation is threatening Riau province due to the high prevalence of DM. Since 2014 Arifin Achmad Hospital as a referral hospital of MDR-TB management. It’s treatment especially in DM patients, requires an evaluation of both outcome and side effects. This evaluation needs to be compared with non-DM MDR TB patients. The aim of this study was to evaluate and analyse patient’s characteristic, conversion of smear or culture, drugs side effect and treatment outcome. Methods: This is a cross sectional retrospective study in RSUD Arifin Achmad Pekanbaru on April-October 2018. Sample of this study were all patients from 2014 – 2017. This study was divided into 2 groups, namely the DM and non-DM groups, then analysed the differences between the two groups Results: There were 113 MDR TB patients had its treatment, which 61% of the patients were male. Baseline data show 26.5% of MDR TB patients have comorbid DM. The most common side effects were nausea and vomiting (100%) in all subjects. In the MDR TB DM group, we found included: well controlled plasma glucose level was 33.3%, severe side effects was16.7%, conversion in the second month 40% and cured or complete treatment was 30%. Conclusions: As many as 26,5% of MDR TB patients had DM comorbidity. There were no differences in the percentage of drugs side effects, smear conversion in the second month and treatment outcome between MDR TB DM and MDR TB non-DM group. (J Respir Indo. 2020; 40(3): 156-62)
Hemokonsentrasi dan Trombositopenia pada COVID-19, Pembelajaran dari Ruang Instalasi Gawat Darurat Dani Rosdiana; Marlina Tasril; M Firdaus J Karimi
Jurnal Ilmu Kedokteran Vol 17, No 1 (2023): Jurnal Ilmu Kedokteran
Publisher : Fakultas Kedokteran Universitas Riau

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26891/JIK.v17i1.2023.84-89

Abstract

Coronavirus disease 2019 (COVID-19) has become a pandemic since January 2020 and caused the death of 6 million people by April 2022. Exponential human-to-human transmission and the wide variety of clinical and laboratory manifestations of COVID-19 were challenging. Hematological abnormalities such as thrombocytopenia and hemoconcentration in COVID-19 are difficult to distinguish from dengue fever in the ER. Misdiagnosis would impact patient outcomes, health workers, and community safety as well as its transmission. We report a suspected case of dengue fever in admission in X Pekanbaru hospital, Riau which is confirmed as COVID-19. The patient was observed in the isolation ward and treated accordingly to the COVID-19 protocol and heparin due to coagulopathy related to COVID-19. The Proper initial assessment of acute febrile, especially Dengue fever at the emergency room, and the availability of modalities in diagnosing COVID-19 are of paramount importance in the era of the COVID-19 pandemic, even more, it become endemic status.
Co-Authors Dani Rosdiana Dewi Anggraini Indra Yovi M Firdaus J Karimi